Quality Chemical Industries Limited (UGSE:QCIL)

Uganda flag Uganda · Delayed Price · Currency is UGX
119.95
0.00 (0.00%)
At close: Feb 26, 2026
Market Cap438.05B +53.8%
Revenue (ttm)263.07B -11.2%
Net Income42.47B -15.5%
EPS11.63 -15.7%
Shares Out3.65B
PE Ratio10.31
Forward PEn/a
Dividend14.20 (11.84%)
Ex-Dividend DateNov 21, 2025
Volumen/a
Average Volume16,966
Openn/a
Previous Close119.95
Day's Rangen/a
52-Week Range67.68 - 121.00
Beta-0.12
RSI74.64
Earnings DateFeb 9, 2026

About UGSE:QCIL

Quality Chemical Industries Limited manufactures and sells pharmaceutical drugs in Uganda. The company offers lamivudine/tenofovir disoproxil fumarate, dolutegravir, efavirenz, and zidovudine tablets for the treatment of HIV infection. It also provides lumartem/lumet tablets for the treatment of malaria; texavir and zentair for the treatment of Hepatitis B; and isoniazid/pyridoxine hydrochloride /sulfamethoxazole trimethoprim tablets for the treatment of tuberculosis. In addition, the company offers emeset for the treatment of nausea and vomiti... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 362
Stock Exchange Uganda Securities Exchange
Ticker Symbol QCIL
Full Company Profile

Financial Performance

In fiscal year 2025, UGSE:QCIL's revenue was 267.13 billion, an increase of 0.67% compared to the previous year's 265.34 billion. Earnings were 40.65 billion, an increase of 28.00%.

Financial Statements